Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DANAHER CORPORATION

(DHR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Danaher : Unit, Cytiva Team Up to Invest $1.5 Billion to Expand Manufacturing Capacity for Biotechnology Solutions

07/27/2021 | 05:08am EDT


© MT Newswires 2021
All news about DANAHER CORPORATION
09/15DANAHER CORP /DE/ : Change in Directors or Principal Officers, Financial Stateme..
AQ
09/14DANAHER : Keeps Quarterly Cash Dividend Unchanged at $0.21 a Share, Payable Oct...
MT
09/14DANAHER : Announces Quarterly Dividends
PR
09/14Danaher Corporation Approves Regular Quarterly Cash Dividend, Payable on Octo..
CI
09/10DANAHER : Credit Suisse Raises Danaher's PT to $370 from $306, Notes Heightened ..
MT
09/08DANAHER : RBC Raises Price Target on Danaher to $332 From $304 Ahead of Analyst ..
MT
09/03DANAHER : Helping Customers Make Better Beer -- and Improve Sustainability
PU
09/01SCIEX : Presents Industry First Multi-Capillary System for CE-SDS, the BioPhase ..
BU
09/01SCIEX : Builds on Cadence of Innovation in Biopharma With Biologics Explorer
BU
08/30DANAHER : Closes $9.6 Billion Acquisition Deal for Aldevron
MT
More news
Analyst Recommendations on DANAHER CORPORATION
More recommendations
Financials (USD)
Sales 2021 28 687 M - -
Net income 2021 6 144 M - -
Net Debt 2021 14 651 M - -
P/E ratio 2021 39,1x
Yield 2021 0,27%
Capitalization 232 B 232 B -
EV / Sales 2021 8,59x
EV / Sales 2022 7,98x
Nbr of Employees 68 000
Free-Float 74,2%
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 324,53 $
Average target price 327,00 $
Spread / Average Target 0,76%
EPS Revisions
Managers and Directors
Rainer M. Blair President, Chief Executive Officer & Director
Matthew R. McGrew Chief Financial Officer & Executive Vice President
Steven M. Rales Chairman
Jose Carlos Gutiérrez Ramos Chief Science Officer & Senior Vice President
Brian W. Ellis Senior Vice President & General Counsel
Sector and Competitors